NEW DELHI: Dr Reddy’s has entered right into a licence settlement with Pharmazz, a US based mostly biopharmaceutical firm, to commercialise a first-in-class progressive drug Centhaquine in India.Developed by Pharmazz, Centhaquine is a resuscitative agent, presently indicated for the remedy of hypovolemic shock, by the Medicine Controller Common of India…
